Litcius/Paper detail

Retrospective analysis of adverse events with dupilumab reported to the United States Food and Drug Administration

Yu Wang, Joseph L. Jorizzo

2021Journal of the American Academy of Dermatology30 citationsDOI

Topics & Concepts

DupilumabMedicinePimecrolimusAtopic dermatitisTacrolimusAdverse effectDermatologyPlaceboInternal medicinePathologyTransplantationAlternative medicineDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisTryptophan and brain disorders
Retrospective analysis of adverse events with dupilumab reported to the United States Food and Drug Administration | Litcius